NAVEED HYDERI: Open Payments
NPI 1912994054 · CICERO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 64 payments from 21 companies in 2025. Trend: 2023 $198 · 2024 $1,349 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $204 |
| Amgen Inc. | 9 | $148 |
| Phathom Pharmaceuticals, Inc. | 5 | $109 |
| PFIZER INC. | 5 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $91 |
| Noven Therapeutics, LLC | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
Products named: REXULTI, VOQUEZNA, AUSTEDO XR, REPATHA, Xelstrym, CAPLYTA, XIFAXAN, Kerendia.
Industry payments across IL — which companies pay providers there.
